nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—Topoisomerase Inhibitors—Mitoxantrone—prostate cancer	0.213	0.354	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Etoposide—prostate cancer	0.167	0.278	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Epirubicin—prostate cancer	0.115	0.191	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—prostate cancer	0.107	0.177	CiPCiCtD
Topotecan—CYP3A4—prostate cancer	0.0631	1	CbGaD
Topotecan—ABCG2—Cabazitaxel—prostate cancer	0.0196	0.0935	CbGbCtD
Topotecan—ABCG2—Estrone—prostate cancer	0.0191	0.0914	CbGbCtD
Topotecan—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0131	0.0628	CbGbCtD
Topotecan—ABCG2—Conjugated Estrogens—prostate cancer	0.0125	0.0598	CbGbCtD
Topotecan—ABCG2—Mitoxantrone—prostate cancer	0.0114	0.0544	CbGbCtD
Topotecan—ABCG2—Estradiol—prostate cancer	0.011	0.0525	CbGbCtD
Topotecan—ABCB1—Estramustine—prostate cancer	0.0107	0.0512	CbGbCtD
Topotecan—ABCG2—Etoposide—prostate cancer	0.00718	0.0343	CbGbCtD
Topotecan—ABCB1—Cabazitaxel—prostate cancer	0.00706	0.0337	CbGbCtD
Topotecan—CYP3A4—Bicalutamide—prostate cancer	0.0069	0.033	CbGbCtD
Topotecan—ABCB1—Estrone—prostate cancer	0.0069	0.033	CbGbCtD
Topotecan—ABCG2—Docetaxel—prostate cancer	0.00657	0.0314	CbGbCtD
Topotecan—CYP3A4—Estramustine—prostate cancer	0.00642	0.0306	CbGbCtD
Topotecan—ABCB1—Ethinyl Estradiol—prostate cancer	0.00615	0.0294	CbGbCtD
Topotecan—CYP3A4—Flutamide—prostate cancer	0.00572	0.0273	CbGbCtD
Topotecan—CYP3A4—Abiraterone—prostate cancer	0.00572	0.0273	CbGbCtD
Topotecan—ABCG2—Doxorubicin—prostate cancer	0.0049	0.0234	CbGbCtD
Topotecan—ABCB1—Conjugated Estrogens—prostate cancer	0.00452	0.0216	CbGbCtD
Topotecan—CYP3A4—Cabazitaxel—prostate cancer	0.00423	0.0202	CbGbCtD
Topotecan—CYP3A4—Estrone—prostate cancer	0.00414	0.0197	CbGbCtD
Topotecan—ABCB1—Mitoxantrone—prostate cancer	0.00411	0.0196	CbGbCtD
Topotecan—ABCB1—Estradiol—prostate cancer	0.00397	0.0189	CbGbCtD
Topotecan—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00369	0.0176	CbGbCtD
Topotecan—ABCB1—Prednisone—prostate cancer	0.00341	0.0163	CbGbCtD
Topotecan—CYP3A4—Conjugated Estrogens—prostate cancer	0.00271	0.0129	CbGbCtD
Topotecan—ABCB1—Etoposide—prostate cancer	0.00259	0.0124	CbGbCtD
Topotecan—TOP1MT—prostate gland—prostate cancer	0.00247	0.185	CbGeAlD
Topotecan—CYP3A4—Mitoxantrone—prostate cancer	0.00246	0.0117	CbGbCtD
Topotecan—CYP3A4—Estradiol—prostate cancer	0.00238	0.0113	CbGbCtD
Topotecan—ABCB1—Docetaxel—prostate cancer	0.00237	0.0113	CbGbCtD
Topotecan—CYP3A4—Prednisone—prostate cancer	0.00204	0.00975	CbGbCtD
Topotecan—ABCB1—Doxorubicin—prostate cancer	0.00177	0.00843	CbGbCtD
Topotecan—CYP3A4—Etoposide—prostate cancer	0.00155	0.00741	CbGbCtD
Topotecan—CYP3A4—Docetaxel—prostate cancer	0.00142	0.00678	CbGbCtD
Topotecan—TOP1—prostate gland—prostate cancer	0.0013	0.0977	CbGeAlD
Topotecan—TOP1—seminal vesicle—prostate cancer	0.0011	0.0826	CbGeAlD
Topotecan—TOP1MT—testis—prostate cancer	0.00109	0.0816	CbGeAlD
Topotecan—CYP3A4—Doxorubicin—prostate cancer	0.00106	0.00505	CbGbCtD
Topotecan—CYP3A4—urine—prostate cancer	0.000897	0.0672	CbGeAlD
Topotecan—TOP1—urethra—prostate cancer	0.000873	0.0654	CbGeAlD
Topotecan—TOP1MT—lymph node—prostate cancer	0.000789	0.0591	CbGeAlD
Topotecan—Irinotecan—SLC22A3—prostate cancer	0.000693	0.366	CrCbGaD
Topotecan—TOP1—bone marrow—prostate cancer	0.000672	0.0503	CbGeAlD
Topotecan—Irinotecan—ACHE—prostate cancer	0.000627	0.331	CrCbGaD
Topotecan—TOP1—testis—prostate cancer	0.000574	0.043	CbGeAlD
Topotecan—ABCG2—prostate gland—prostate cancer	0.000462	0.0346	CbGeAlD
Topotecan—TOP1—lymph node—prostate cancer	0.000416	0.0312	CbGeAlD
Topotecan—Irinotecan—CYP3A5—prostate cancer	0.000401	0.212	CrCbGaD
Topotecan—ABCG2—seminal vesicle—prostate cancer	0.000391	0.0293	CbGeAlD
Topotecan—ABCG2—urethra—prostate cancer	0.00031	0.0232	CbGeAlD
Topotecan—ABCG2—bone marrow—prostate cancer	0.000238	0.0179	CbGeAlD
Topotecan—ABCB1—prostate gland—prostate cancer	0.000228	0.0171	CbGeAlD
Topotecan—CYP3A4—renal system—prostate cancer	0.00022	0.0165	CbGeAlD
Topotecan—ABCG2—testis—prostate cancer	0.000204	0.0153	CbGeAlD
Topotecan—ABCB1—seminal vesicle—prostate cancer	0.000193	0.0145	CbGeAlD
Topotecan—Irinotecan—CYP3A4—prostate cancer	0.000173	0.0916	CrCbGaD
Topotecan—ABCB1—epithelium—prostate cancer	0.000168	0.0126	CbGeAlD
Topotecan—ABCB1—renal system—prostate cancer	0.000155	0.0116	CbGeAlD
Topotecan—ABCB1—urethra—prostate cancer	0.000153	0.0114	CbGeAlD
Topotecan—ABCG2—lymph node—prostate cancer	0.000148	0.0111	CbGeAlD
Topotecan—ABCB1—bone marrow—prostate cancer	0.000118	0.0088	CbGeAlD
Topotecan—ABCB1—testis—prostate cancer	0.0001	0.00753	CbGeAlD
Topotecan—ABCB1—lymph node—prostate cancer	7.28e-05	0.00546	CbGeAlD
Topotecan—Stomatitis—Epirubicin—prostate cancer	2.33e-05	0.000292	CcSEcCtD
Topotecan—Constipation—Etoposide—prostate cancer	2.32e-05	0.000291	CcSEcCtD
Topotecan—Pain—Etoposide—prostate cancer	2.32e-05	0.000291	CcSEcCtD
Topotecan—Dizziness—Estradiol—prostate cancer	2.32e-05	0.000291	CcSEcCtD
Topotecan—Neutropenia—Doxorubicin—prostate cancer	2.32e-05	0.00029	CcSEcCtD
Topotecan—Sweating—Epirubicin—prostate cancer	2.29e-05	0.000287	CcSEcCtD
Topotecan—Arthralgia—Capecitabine—prostate cancer	2.28e-05	0.000286	CcSEcCtD
Topotecan—Chest pain—Capecitabine—prostate cancer	2.28e-05	0.000286	CcSEcCtD
Topotecan—Myalgia—Capecitabine—prostate cancer	2.28e-05	0.000286	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	2.27e-05	0.000284	CcSEcCtD
Topotecan—Hepatobiliary disease—Epirubicin—prostate cancer	2.26e-05	0.000283	CcSEcCtD
Topotecan—Anaphylactic shock—Docetaxel—prostate cancer	2.26e-05	0.000283	CcSEcCtD
Topotecan—Weight increased—Doxorubicin—prostate cancer	2.26e-05	0.000283	CcSEcCtD
Topotecan—Discomfort—Capecitabine—prostate cancer	2.25e-05	0.000282	CcSEcCtD
Topotecan—Epistaxis—Epirubicin—prostate cancer	2.25e-05	0.000282	CcSEcCtD
Topotecan—Infection—Docetaxel—prostate cancer	2.24e-05	0.000281	CcSEcCtD
Topotecan—Feeling abnormal—Etoposide—prostate cancer	2.24e-05	0.000281	CcSEcCtD
Topotecan—Diarrhoea—Mitoxantrone—prostate cancer	2.24e-05	0.00028	CcSEcCtD
Topotecan—Vomiting—Estradiol—prostate cancer	2.23e-05	0.000279	CcSEcCtD
Topotecan—Pneumonia—Doxorubicin—prostate cancer	2.22e-05	0.000279	CcSEcCtD
Topotecan—Gastrointestinal pain—Etoposide—prostate cancer	2.22e-05	0.000278	CcSEcCtD
Topotecan—Nervous system disorder—Docetaxel—prostate cancer	2.22e-05	0.000278	CcSEcCtD
Topotecan—Ill-defined disorder—Prednisone—prostate cancer	2.21e-05	0.000277	CcSEcCtD
Topotecan—Thrombocytopenia—Docetaxel—prostate cancer	2.21e-05	0.000277	CcSEcCtD
Topotecan—Rash—Estradiol—prostate cancer	2.21e-05	0.000277	CcSEcCtD
Topotecan—Infestation NOS—Doxorubicin—prostate cancer	2.21e-05	0.000277	CcSEcCtD
Topotecan—Infestation—Doxorubicin—prostate cancer	2.21e-05	0.000277	CcSEcCtD
Topotecan—Dermatitis—Estradiol—prostate cancer	2.21e-05	0.000277	CcSEcCtD
Topotecan—Anaemia—Prednisone—prostate cancer	2.21e-05	0.000276	CcSEcCtD
Topotecan—Headache—Estradiol—prostate cancer	2.2e-05	0.000275	CcSEcCtD
Topotecan—Skin disorder—Docetaxel—prostate cancer	2.19e-05	0.000275	CcSEcCtD
Topotecan—Angioedema—Prednisone—prostate cancer	2.18e-05	0.000273	CcSEcCtD
Topotecan—Infection—Capecitabine—prostate cancer	2.17e-05	0.000272	CcSEcCtD
Topotecan—Neuropathy peripheral—Doxorubicin—prostate cancer	2.17e-05	0.000271	CcSEcCtD
Topotecan—Urticaria—Etoposide—prostate cancer	2.16e-05	0.000271	CcSEcCtD
Topotecan—Haemoglobin—Epirubicin—prostate cancer	2.16e-05	0.00027	CcSEcCtD
Topotecan—Stomatitis—Doxorubicin—prostate cancer	2.15e-05	0.00027	CcSEcCtD
Topotecan—Anorexia—Docetaxel—prostate cancer	2.15e-05	0.00027	CcSEcCtD
Topotecan—Malaise—Prednisone—prostate cancer	2.15e-05	0.00027	CcSEcCtD
Topotecan—Rhinitis—Epirubicin—prostate cancer	2.15e-05	0.000269	CcSEcCtD
Topotecan—Abdominal pain—Etoposide—prostate cancer	2.15e-05	0.000269	CcSEcCtD
Topotecan—Body temperature increased—Etoposide—prostate cancer	2.15e-05	0.000269	CcSEcCtD
Topotecan—Nervous system disorder—Capecitabine—prostate cancer	2.14e-05	0.000269	CcSEcCtD
Topotecan—Haemorrhage—Epirubicin—prostate cancer	2.14e-05	0.000269	CcSEcCtD
Topotecan—Thrombocytopenia—Capecitabine—prostate cancer	2.14e-05	0.000268	CcSEcCtD
Topotecan—Hypoaesthesia—Epirubicin—prostate cancer	2.13e-05	0.000267	CcSEcCtD
Topotecan—Pharyngitis—Epirubicin—prostate cancer	2.13e-05	0.000267	CcSEcCtD
Topotecan—Skin disorder—Capecitabine—prostate cancer	2.12e-05	0.000266	CcSEcCtD
Topotecan—Sweating—Doxorubicin—prostate cancer	2.12e-05	0.000266	CcSEcCtD
Topotecan—Hyperhidrosis—Capecitabine—prostate cancer	2.11e-05	0.000265	CcSEcCtD
Topotecan—Hepatobiliary disease—Doxorubicin—prostate cancer	2.09e-05	0.000262	CcSEcCtD
Topotecan—Epistaxis—Doxorubicin—prostate cancer	2.09e-05	0.000261	CcSEcCtD
Topotecan—Anorexia—Capecitabine—prostate cancer	2.08e-05	0.000261	CcSEcCtD
Topotecan—Nausea—Estradiol—prostate cancer	2.08e-05	0.000261	CcSEcCtD
Topotecan—Vomiting—Mitoxantrone—prostate cancer	2.08e-05	0.00026	CcSEcCtD
Topotecan—Rash—Mitoxantrone—prostate cancer	2.06e-05	0.000258	CcSEcCtD
Topotecan—Dermatitis—Mitoxantrone—prostate cancer	2.06e-05	0.000258	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.06e-05	0.000258	CcSEcCtD
Topotecan—Headache—Mitoxantrone—prostate cancer	2.05e-05	0.000256	CcSEcCtD
Topotecan—Arthralgia—Prednisone—prostate cancer	2.03e-05	0.000255	CcSEcCtD
Topotecan—Myalgia—Prednisone—prostate cancer	2.03e-05	0.000255	CcSEcCtD
Topotecan—Paraesthesia—Docetaxel—prostate cancer	2.03e-05	0.000254	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.02e-05	0.000253	CcSEcCtD
Topotecan—Dyspnoea—Docetaxel—prostate cancer	2.01e-05	0.000252	CcSEcCtD
Topotecan—Discomfort—Prednisone—prostate cancer	2.01e-05	0.000252	CcSEcCtD
Topotecan—Hypersensitivity—Etoposide—prostate cancer	2e-05	0.000251	CcSEcCtD
Topotecan—Haemoglobin—Doxorubicin—prostate cancer	1.99e-05	0.00025	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.99e-05	0.00025	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—prostate cancer	1.99e-05	0.000249	CcSEcCtD
Topotecan—Dyspepsia—Docetaxel—prostate cancer	1.99e-05	0.000249	CcSEcCtD
Topotecan—Haemorrhage—Doxorubicin—prostate cancer	1.98e-05	0.000249	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—prostate cancer	1.97e-05	0.000247	CcSEcCtD
Topotecan—Pharyngitis—Doxorubicin—prostate cancer	1.97e-05	0.000247	CcSEcCtD
Topotecan—Paraesthesia—Capecitabine—prostate cancer	1.96e-05	0.000246	CcSEcCtD
Topotecan—Decreased appetite—Docetaxel—prostate cancer	1.96e-05	0.000246	CcSEcCtD
Topotecan—Gastrointestinal disorder—Docetaxel—prostate cancer	1.95e-05	0.000244	CcSEcCtD
Topotecan—Asthenia—Etoposide—prostate cancer	1.95e-05	0.000244	CcSEcCtD
Topotecan—Dyspnoea—Capecitabine—prostate cancer	1.95e-05	0.000244	CcSEcCtD
Topotecan—Anaphylactic shock—Prednisone—prostate cancer	1.95e-05	0.000244	CcSEcCtD
Topotecan—Fatigue—Docetaxel—prostate cancer	1.95e-05	0.000244	CcSEcCtD
Topotecan—Angiopathy—Epirubicin—prostate cancer	1.95e-05	0.000244	CcSEcCtD
Topotecan—Nausea—Mitoxantrone—prostate cancer	1.94e-05	0.000243	CcSEcCtD
Topotecan—Immune system disorder—Epirubicin—prostate cancer	1.94e-05	0.000243	CcSEcCtD
Topotecan—Infection—Prednisone—prostate cancer	1.94e-05	0.000242	CcSEcCtD
Topotecan—Mediastinal disorder—Epirubicin—prostate cancer	1.93e-05	0.000242	CcSEcCtD
Topotecan—Constipation—Docetaxel—prostate cancer	1.93e-05	0.000242	CcSEcCtD
Topotecan—Pain—Docetaxel—prostate cancer	1.93e-05	0.000242	CcSEcCtD
Topotecan—Dyspepsia—Capecitabine—prostate cancer	1.93e-05	0.000241	CcSEcCtD
Topotecan—Chills—Epirubicin—prostate cancer	1.92e-05	0.000241	CcSEcCtD
Topotecan—Pruritus—Etoposide—prostate cancer	1.92e-05	0.000241	CcSEcCtD
Topotecan—Nervous system disorder—Prednisone—prostate cancer	1.91e-05	0.000239	CcSEcCtD
Topotecan—Decreased appetite—Capecitabine—prostate cancer	1.9e-05	0.000238	CcSEcCtD
Topotecan—Alopecia—Epirubicin—prostate cancer	1.9e-05	0.000237	CcSEcCtD
Topotecan—Skin disorder—Prednisone—prostate cancer	1.89e-05	0.000237	CcSEcCtD
Topotecan—Gastrointestinal disorder—Capecitabine—prostate cancer	1.89e-05	0.000237	CcSEcCtD
Topotecan—Fatigue—Capecitabine—prostate cancer	1.89e-05	0.000236	CcSEcCtD
Topotecan—Hyperhidrosis—Prednisone—prostate cancer	1.88e-05	0.000236	CcSEcCtD
Topotecan—Pain—Capecitabine—prostate cancer	1.87e-05	0.000234	CcSEcCtD
Topotecan—Constipation—Capecitabine—prostate cancer	1.87e-05	0.000234	CcSEcCtD
Topotecan—Malnutrition—Epirubicin—prostate cancer	1.87e-05	0.000234	CcSEcCtD
Topotecan—Feeling abnormal—Docetaxel—prostate cancer	1.86e-05	0.000233	CcSEcCtD
Topotecan—Diarrhoea—Etoposide—prostate cancer	1.86e-05	0.000233	CcSEcCtD
Topotecan—Anorexia—Prednisone—prostate cancer	1.86e-05	0.000233	CcSEcCtD
Topotecan—Gastrointestinal pain—Docetaxel—prostate cancer	1.85e-05	0.000231	CcSEcCtD
Topotecan—Back pain—Epirubicin—prostate cancer	1.81e-05	0.000226	CcSEcCtD
Topotecan—Feeling abnormal—Capecitabine—prostate cancer	1.8e-05	0.000226	CcSEcCtD
Topotecan—Angiopathy—Doxorubicin—prostate cancer	1.8e-05	0.000226	CcSEcCtD
Topotecan—Dizziness—Etoposide—prostate cancer	1.8e-05	0.000225	CcSEcCtD
Topotecan—Muscle spasms—Epirubicin—prostate cancer	1.79e-05	0.000225	CcSEcCtD
Topotecan—Immune system disorder—Doxorubicin—prostate cancer	1.79e-05	0.000225	CcSEcCtD
Topotecan—Gastrointestinal pain—Capecitabine—prostate cancer	1.79e-05	0.000224	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—prostate cancer	1.79e-05	0.000224	CcSEcCtD
Topotecan—Abdominal pain—Docetaxel—prostate cancer	1.79e-05	0.000224	CcSEcCtD
Topotecan—Body temperature increased—Docetaxel—prostate cancer	1.79e-05	0.000224	CcSEcCtD
Topotecan—Chills—Doxorubicin—prostate cancer	1.78e-05	0.000223	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Prednisone—prostate cancer	1.77e-05	0.000222	CcSEcCtD
Topotecan—Alopecia—Doxorubicin—prostate cancer	1.75e-05	0.00022	CcSEcCtD
Topotecan—Paraesthesia—Prednisone—prostate cancer	1.75e-05	0.000219	CcSEcCtD
Topotecan—Urticaria—Capecitabine—prostate cancer	1.74e-05	0.000218	CcSEcCtD
Topotecan—Ill-defined disorder—Epirubicin—prostate cancer	1.73e-05	0.000217	CcSEcCtD
Topotecan—Abdominal pain—Capecitabine—prostate cancer	1.73e-05	0.000217	CcSEcCtD
Topotecan—Body temperature increased—Capecitabine—prostate cancer	1.73e-05	0.000217	CcSEcCtD
Topotecan—Vomiting—Etoposide—prostate cancer	1.73e-05	0.000217	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—prostate cancer	1.73e-05	0.000216	CcSEcCtD
Topotecan—Anaemia—Epirubicin—prostate cancer	1.73e-05	0.000216	CcSEcCtD
Topotecan—Dyspepsia—Prednisone—prostate cancer	1.71e-05	0.000215	CcSEcCtD
Topotecan—Rash—Etoposide—prostate cancer	1.71e-05	0.000215	CcSEcCtD
Topotecan—Dermatitis—Etoposide—prostate cancer	1.71e-05	0.000215	CcSEcCtD
Topotecan—Headache—Etoposide—prostate cancer	1.7e-05	0.000213	CcSEcCtD
Topotecan—Decreased appetite—Prednisone—prostate cancer	1.69e-05	0.000212	CcSEcCtD
Topotecan—Malaise—Epirubicin—prostate cancer	1.68e-05	0.000211	CcSEcCtD
Topotecan—Fatigue—Prednisone—prostate cancer	1.68e-05	0.00021	CcSEcCtD
Topotecan—Leukopenia—Epirubicin—prostate cancer	1.67e-05	0.000209	CcSEcCtD
Topotecan—Back pain—Doxorubicin—prostate cancer	1.67e-05	0.000209	CcSEcCtD
Topotecan—Constipation—Prednisone—prostate cancer	1.67e-05	0.000209	CcSEcCtD
Topotecan—Hypersensitivity—Docetaxel—prostate cancer	1.66e-05	0.000209	CcSEcCtD
Topotecan—Muscle spasms—Doxorubicin—prostate cancer	1.66e-05	0.000208	CcSEcCtD
Topotecan—Cough—Epirubicin—prostate cancer	1.63e-05	0.000204	CcSEcCtD
Topotecan—Asthenia—Docetaxel—prostate cancer	1.62e-05	0.000203	CcSEcCtD
Topotecan—Nausea—Etoposide—prostate cancer	1.61e-05	0.000202	CcSEcCtD
Topotecan—Hypersensitivity—Capecitabine—prostate cancer	1.61e-05	0.000202	CcSEcCtD
Topotecan—Feeling abnormal—Prednisone—prostate cancer	1.61e-05	0.000201	CcSEcCtD
Topotecan—Ill-defined disorder—Doxorubicin—prostate cancer	1.6e-05	0.000201	CcSEcCtD
Topotecan—Pruritus—Docetaxel—prostate cancer	1.6e-05	0.0002	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—prostate cancer	1.6e-05	0.0002	CcSEcCtD
Topotecan—Gastrointestinal pain—Prednisone—prostate cancer	1.59e-05	0.0002	CcSEcCtD
Topotecan—Myalgia—Epirubicin—prostate cancer	1.59e-05	0.000199	CcSEcCtD
Topotecan—Chest pain—Epirubicin—prostate cancer	1.59e-05	0.000199	CcSEcCtD
Topotecan—Arthralgia—Epirubicin—prostate cancer	1.59e-05	0.000199	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.58e-05	0.000198	CcSEcCtD
Topotecan—Discomfort—Epirubicin—prostate cancer	1.57e-05	0.000197	CcSEcCtD
Topotecan—Asthenia—Capecitabine—prostate cancer	1.57e-05	0.000197	CcSEcCtD
Topotecan—Malaise—Doxorubicin—prostate cancer	1.56e-05	0.000195	CcSEcCtD
Topotecan—Urticaria—Prednisone—prostate cancer	1.55e-05	0.000194	CcSEcCtD
Topotecan—Pruritus—Capecitabine—prostate cancer	1.55e-05	0.000194	CcSEcCtD
Topotecan—Leukopenia—Doxorubicin—prostate cancer	1.55e-05	0.000194	CcSEcCtD
Topotecan—Diarrhoea—Docetaxel—prostate cancer	1.55e-05	0.000194	CcSEcCtD
Topotecan—Body temperature increased—Prednisone—prostate cancer	1.54e-05	0.000193	CcSEcCtD
Topotecan—Abdominal pain—Prednisone—prostate cancer	1.54e-05	0.000193	CcSEcCtD
Topotecan—Anaphylactic shock—Epirubicin—prostate cancer	1.52e-05	0.000191	CcSEcCtD
Topotecan—Infection—Epirubicin—prostate cancer	1.51e-05	0.00019	CcSEcCtD
Topotecan—Cough—Doxorubicin—prostate cancer	1.51e-05	0.000189	CcSEcCtD
Topotecan—Diarrhoea—Capecitabine—prostate cancer	1.5e-05	0.000187	CcSEcCtD
Topotecan—Nervous system disorder—Epirubicin—prostate cancer	1.49e-05	0.000187	CcSEcCtD
Topotecan—Dizziness—Docetaxel—prostate cancer	1.49e-05	0.000187	CcSEcCtD
Topotecan—Thrombocytopenia—Epirubicin—prostate cancer	1.49e-05	0.000187	CcSEcCtD
Topotecan—Skin disorder—Epirubicin—prostate cancer	1.48e-05	0.000185	CcSEcCtD
Topotecan—Hyperhidrosis—Epirubicin—prostate cancer	1.47e-05	0.000185	CcSEcCtD
Topotecan—Arthralgia—Doxorubicin—prostate cancer	1.47e-05	0.000184	CcSEcCtD
Topotecan—Chest pain—Doxorubicin—prostate cancer	1.47e-05	0.000184	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—prostate cancer	1.47e-05	0.000184	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.46e-05	0.000183	CcSEcCtD
Topotecan—Discomfort—Doxorubicin—prostate cancer	1.45e-05	0.000182	CcSEcCtD
Topotecan—Anorexia—Epirubicin—prostate cancer	1.45e-05	0.000182	CcSEcCtD
Topotecan—Dizziness—Capecitabine—prostate cancer	1.45e-05	0.000181	CcSEcCtD
Topotecan—Vomiting—Docetaxel—prostate cancer	1.44e-05	0.00018	CcSEcCtD
Topotecan—Hypersensitivity—Prednisone—prostate cancer	1.44e-05	0.00018	CcSEcCtD
Topotecan—Rash—Docetaxel—prostate cancer	1.42e-05	0.000178	CcSEcCtD
Topotecan—Dermatitis—Docetaxel—prostate cancer	1.42e-05	0.000178	CcSEcCtD
Topotecan—Headache—Docetaxel—prostate cancer	1.42e-05	0.000177	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—prostate cancer	1.41e-05	0.000177	CcSEcCtD
Topotecan—Infection—Doxorubicin—prostate cancer	1.4e-05	0.000175	CcSEcCtD
Topotecan—Asthenia—Prednisone—prostate cancer	1.4e-05	0.000175	CcSEcCtD
Topotecan—Vomiting—Capecitabine—prostate cancer	1.39e-05	0.000174	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.39e-05	0.000174	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—prostate cancer	1.38e-05	0.000173	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—prostate cancer	1.38e-05	0.000173	CcSEcCtD
Topotecan—Rash—Capecitabine—prostate cancer	1.38e-05	0.000173	CcSEcCtD
Topotecan—Pruritus—Prednisone—prostate cancer	1.38e-05	0.000173	CcSEcCtD
Topotecan—Dermatitis—Capecitabine—prostate cancer	1.38e-05	0.000173	CcSEcCtD
Topotecan—Headache—Capecitabine—prostate cancer	1.37e-05	0.000172	CcSEcCtD
Topotecan—Skin disorder—Doxorubicin—prostate cancer	1.37e-05	0.000172	CcSEcCtD
Topotecan—Paraesthesia—Epirubicin—prostate cancer	1.37e-05	0.000171	CcSEcCtD
Topotecan—Hyperhidrosis—Doxorubicin—prostate cancer	1.36e-05	0.000171	CcSEcCtD
Topotecan—Dyspnoea—Epirubicin—prostate cancer	1.36e-05	0.00017	CcSEcCtD
Topotecan—Anorexia—Doxorubicin—prostate cancer	1.34e-05	0.000168	CcSEcCtD
Topotecan—Nausea—Docetaxel—prostate cancer	1.34e-05	0.000168	CcSEcCtD
Topotecan—Dyspepsia—Epirubicin—prostate cancer	1.34e-05	0.000168	CcSEcCtD
Topotecan—Diarrhoea—Prednisone—prostate cancer	1.33e-05	0.000167	CcSEcCtD
Topotecan—Decreased appetite—Epirubicin—prostate cancer	1.32e-05	0.000166	CcSEcCtD
Topotecan—Gastrointestinal disorder—Epirubicin—prostate cancer	1.32e-05	0.000165	CcSEcCtD
Topotecan—Fatigue—Epirubicin—prostate cancer	1.31e-05	0.000165	CcSEcCtD
Topotecan—Constipation—Epirubicin—prostate cancer	1.3e-05	0.000163	CcSEcCtD
Topotecan—Pain—Epirubicin—prostate cancer	1.3e-05	0.000163	CcSEcCtD
Topotecan—Nausea—Capecitabine—prostate cancer	1.3e-05	0.000163	CcSEcCtD
Topotecan—Dizziness—Prednisone—prostate cancer	1.29e-05	0.000161	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.28e-05	0.000161	CcSEcCtD
Topotecan—Paraesthesia—Doxorubicin—prostate cancer	1.27e-05	0.000159	CcSEcCtD
Topotecan—Dyspnoea—Doxorubicin—prostate cancer	1.26e-05	0.000157	CcSEcCtD
Topotecan—Feeling abnormal—Epirubicin—prostate cancer	1.26e-05	0.000157	CcSEcCtD
Topotecan—Gastrointestinal pain—Epirubicin—prostate cancer	1.25e-05	0.000156	CcSEcCtD
Topotecan—Dyspepsia—Doxorubicin—prostate cancer	1.24e-05	0.000155	CcSEcCtD
Topotecan—Vomiting—Prednisone—prostate cancer	1.24e-05	0.000155	CcSEcCtD
Topotecan—Rash—Prednisone—prostate cancer	1.23e-05	0.000154	CcSEcCtD
Topotecan—Dermatitis—Prednisone—prostate cancer	1.23e-05	0.000154	CcSEcCtD
Topotecan—Decreased appetite—Doxorubicin—prostate cancer	1.23e-05	0.000154	CcSEcCtD
Topotecan—Headache—Prednisone—prostate cancer	1.22e-05	0.000153	CcSEcCtD
Topotecan—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.22e-05	0.000152	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—prostate cancer	1.22e-05	0.000152	CcSEcCtD
Topotecan—Urticaria—Epirubicin—prostate cancer	1.21e-05	0.000152	CcSEcCtD
Topotecan—Pain—Doxorubicin—prostate cancer	1.21e-05	0.000151	CcSEcCtD
Topotecan—Constipation—Doxorubicin—prostate cancer	1.21e-05	0.000151	CcSEcCtD
Topotecan—Abdominal pain—Epirubicin—prostate cancer	1.2e-05	0.000151	CcSEcCtD
Topotecan—Body temperature increased—Epirubicin—prostate cancer	1.2e-05	0.000151	CcSEcCtD
Topotecan—Feeling abnormal—Doxorubicin—prostate cancer	1.16e-05	0.000146	CcSEcCtD
Topotecan—Nausea—Prednisone—prostate cancer	1.16e-05	0.000145	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—prostate cancer	1.15e-05	0.000144	CcSEcCtD
Topotecan—Hypersensitivity—Epirubicin—prostate cancer	1.12e-05	0.000141	CcSEcCtD
Topotecan—Urticaria—Doxorubicin—prostate cancer	1.12e-05	0.00014	CcSEcCtD
Topotecan—Abdominal pain—Doxorubicin—prostate cancer	1.11e-05	0.00014	CcSEcCtD
Topotecan—Body temperature increased—Doxorubicin—prostate cancer	1.11e-05	0.00014	CcSEcCtD
Topotecan—Asthenia—Epirubicin—prostate cancer	1.09e-05	0.000137	CcSEcCtD
Topotecan—Pruritus—Epirubicin—prostate cancer	1.08e-05	0.000135	CcSEcCtD
Topotecan—Diarrhoea—Epirubicin—prostate cancer	1.04e-05	0.000131	CcSEcCtD
Topotecan—Hypersensitivity—Doxorubicin—prostate cancer	1.04e-05	0.00013	CcSEcCtD
Topotecan—Asthenia—Doxorubicin—prostate cancer	1.01e-05	0.000127	CcSEcCtD
Topotecan—Dizziness—Epirubicin—prostate cancer	1.01e-05	0.000126	CcSEcCtD
Topotecan—Pruritus—Doxorubicin—prostate cancer	9.97e-06	0.000125	CcSEcCtD
Topotecan—Vomiting—Epirubicin—prostate cancer	9.69e-06	0.000121	CcSEcCtD
Topotecan—Diarrhoea—Doxorubicin—prostate cancer	9.65e-06	0.000121	CcSEcCtD
Topotecan—Rash—Epirubicin—prostate cancer	9.61e-06	0.00012	CcSEcCtD
Topotecan—Dermatitis—Epirubicin—prostate cancer	9.6e-06	0.00012	CcSEcCtD
Topotecan—Headache—Epirubicin—prostate cancer	9.55e-06	0.00012	CcSEcCtD
Topotecan—Dizziness—Doxorubicin—prostate cancer	9.32e-06	0.000117	CcSEcCtD
Topotecan—Nausea—Epirubicin—prostate cancer	9.05e-06	0.000113	CcSEcCtD
Topotecan—Vomiting—Doxorubicin—prostate cancer	8.96e-06	0.000112	CcSEcCtD
Topotecan—Rash—Doxorubicin—prostate cancer	8.89e-06	0.000111	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—prostate cancer	8.88e-06	0.000111	CcSEcCtD
Topotecan—Headache—Doxorubicin—prostate cancer	8.83e-06	0.000111	CcSEcCtD
Topotecan—Nausea—Doxorubicin—prostate cancer	8.37e-06	0.000105	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.53e-06	0.000185	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	5.51e-06	0.000184	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	5.43e-06	0.000182	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—B4GALT4—prostate cancer	5.42e-06	0.000182	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HPGD—prostate cancer	5.42e-06	0.000182	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOA3—prostate cancer	5.42e-06	0.000181	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	5.35e-06	0.000179	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	5.23e-06	0.000175	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.22e-06	0.000175	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HPGDS—prostate cancer	5.17e-06	0.000173	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2C19—prostate cancer	5.13e-06	0.000172	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TNFRSF21—prostate cancer	5.1e-06	0.000171	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTT1—prostate cancer	5.01e-06	0.000168	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ACHE—prostate cancer	5.01e-06	0.000168	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.98e-06	0.000167	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTAP—prostate cancer	4.96e-06	0.000166	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP7B1—prostate cancer	4.96e-06	0.000166	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	4.95e-06	0.000166	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2A6—prostate cancer	4.95e-06	0.000166	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	4.86e-06	0.000163	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SULT1E1—prostate cancer	4.83e-06	0.000162	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SRD5A1—prostate cancer	4.83e-06	0.000162	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKR1C3—prostate cancer	4.82e-06	0.000161	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PRKACB—prostate cancer	4.79e-06	0.00016	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP17A1—prostate cancer	4.74e-06	0.000159	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TST—prostate cancer	4.74e-06	0.000159	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GRHL1—prostate cancer	4.74e-06	0.000159	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PSAT1—prostate cancer	4.74e-06	0.000159	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CBR1—prostate cancer	4.74e-06	0.000159	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CSAD—prostate cancer	4.74e-06	0.000159	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADI1—prostate cancer	4.74e-06	0.000159	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	4.73e-06	0.000158	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.69e-06	0.000157	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	4.68e-06	0.000157	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ACSL4—prostate cancer	4.61e-06	0.000154	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSD17B3—prostate cancer	4.61e-06	0.000154	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	4.57e-06	0.000153	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	4.56e-06	0.000153	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOA2—prostate cancer	4.52e-06	0.000151	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ARG2—prostate cancer	4.42e-06	0.000148	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UMPS—prostate cancer	4.42e-06	0.000148	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PHGDH—prostate cancer	4.42e-06	0.000148	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UGT2B15—prostate cancer	4.41e-06	0.000148	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UGT2B17—prostate cancer	4.41e-06	0.000148	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GRHPR—prostate cancer	4.41e-06	0.000148	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CKMT2—prostate cancer	4.41e-06	0.000148	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.4e-06	0.000147	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	4.35e-06	0.000146	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LDHB—prostate cancer	4.33e-06	0.000145	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC5A5—prostate cancer	4.31e-06	0.000144	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP3A5—prostate cancer	4.25e-06	0.000142	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	4.23e-06	0.000142	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2E1—prostate cancer	4.21e-06	0.000141	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	4.18e-06	0.00014	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NQO1—prostate cancer	4.16e-06	0.000139	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SULT2B1—prostate cancer	4.14e-06	0.000139	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PGAM2—prostate cancer	4.14e-06	0.000139	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—RFK—prostate cancer	4.14e-06	0.000139	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AOX1—prostate cancer	4.14e-06	0.000139	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MBTPS1—prostate cancer	4.14e-06	0.000139	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM3—prostate cancer	4.14e-06	0.000139	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NAGLU—prostate cancer	4.14e-06	0.000139	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	4.12e-06	0.000138	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PDHA1—prostate cancer	4.11e-06	0.000138	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TCN2—prostate cancer	4.11e-06	0.000138	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA3—prostate cancer	4.11e-06	0.000138	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UCP3—prostate cancer	4.11e-06	0.000138	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TH—prostate cancer	4.1e-06	0.000137	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP3A4—prostate cancer	4.06e-06	0.000136	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1B1—prostate cancer	3.99e-06	0.000134	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AMACR—prostate cancer	3.93e-06	0.000132	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP3A43—prostate cancer	3.93e-06	0.000132	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SRD5A2—prostate cancer	3.93e-06	0.000132	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NAT1—prostate cancer	3.93e-06	0.000132	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—DEGS1—prostate cancer	3.93e-06	0.000132	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSD3B1—prostate cancer	3.92e-06	0.000131	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC22A3—prostate cancer	3.92e-06	0.000131	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GGT1—prostate cancer	3.87e-06	0.000129	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOA1—prostate cancer	3.81e-06	0.000128	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	3.79e-06	0.000127	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	3.78e-06	0.000127	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TBXAS1—prostate cancer	3.76e-06	0.000126	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA4—prostate cancer	3.76e-06	0.000126	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP19A1—prostate cancer	3.75e-06	0.000126	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSD17B1—prostate cancer	3.75e-06	0.000125	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	3.71e-06	0.000124	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA2—prostate cancer	3.66e-06	0.000123	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—RXRA—prostate cancer	3.62e-06	0.000121	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCG5—prostate cancer	3.62e-06	0.000121	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SULT1A1—prostate cancer	3.62e-06	0.000121	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA1—prostate cancer	3.53e-06	0.000118	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	3.5e-06	0.000117	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSD3B2—prostate cancer	3.49e-06	0.000117	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTO1—prostate cancer	3.49e-06	0.000117	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NAT2—prostate cancer	3.49e-06	0.000117	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—COMT—prostate cancer	3.49e-06	0.000117	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTP1—prostate cancer	3.47e-06	0.000116	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ITPR1—prostate cancer	3.42e-06	0.000114	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLCB2—prostate cancer	3.35e-06	0.000112	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LRP2—prostate cancer	3.35e-06	0.000112	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2C18—prostate cancer	3.35e-06	0.000112	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.34e-06	0.000112	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HPGD—prostate cancer	3.34e-06	0.000112	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—P4HB—prostate cancer	3.29e-06	0.00011	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TYMS—prostate cancer	3.23e-06	0.000108	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	3.22e-06	0.000108	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC22A1—prostate cancer	3.2e-06	0.000107	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.19e-06	0.000107	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTM1—prostate cancer	3.19e-06	0.000107	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.14e-06	0.000105	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LPL—prostate cancer	3.13e-06	0.000105	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SULT2A1—prostate cancer	3.11e-06	0.000104	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	3.11e-06	0.000104	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MED12—prostate cancer	3.06e-06	0.000103	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.06e-06	0.000102	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTAP—prostate cancer	3.06e-06	0.000102	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GNG5—prostate cancer	3.04e-06	0.000102	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1A1—prostate cancer	3.03e-06	0.000101	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ERCC2—prostate cancer	3e-06	0.0001	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SULT1E1—prostate cancer	2.98e-06	9.97e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SRD5A1—prostate cancer	2.98e-06	9.97e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOA3—prostate cancer	2.93e-06	9.8e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ACSL4—prostate cancer	2.84e-06	9.51e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.84e-06	9.51e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—prostate cancer	2.82e-06	9.44e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HPGDS—prostate cancer	2.79e-06	9.35e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2C19—prostate cancer	2.78e-06	9.29e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARA—prostate cancer	2.77e-06	9.27e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UMPS—prostate cancer	2.72e-06	9.12e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PHGDH—prostate cancer	2.72e-06	9.12e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ARG2—prostate cancer	2.72e-06	9.12e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ACHE—prostate cancer	2.71e-06	9.07e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTT1—prostate cancer	2.71e-06	9.07e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2A6—prostate cancer	2.68e-06	8.97e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LDHB—prostate cancer	2.67e-06	8.94e-05	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.63e-06	8.8e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.62e-06	8.78e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKR1C3—prostate cancer	2.61e-06	8.72e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAV1—prostate cancer	2.6e-06	8.71e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PRKACB—prostate cancer	2.59e-06	8.68e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP17A1—prostate cancer	2.56e-06	8.59e-05	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.54e-06	8.49e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PDHA1—prostate cancer	2.53e-06	8.48e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UCP3—prostate cancer	2.53e-06	8.48e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TCN2—prostate cancer	2.53e-06	8.48e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA3—prostate cancer	2.53e-06	8.48e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOA2—prostate cancer	2.44e-06	8.18e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.42e-06	8.09e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.42e-06	8.09e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CG—prostate cancer	2.37e-06	7.93e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC5A5—prostate cancer	2.33e-06	7.81e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA4—prostate cancer	2.32e-06	7.75e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.32e-06	7.75e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2E1—prostate cancer	2.28e-06	7.62e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA2—prostate cancer	2.26e-06	7.55e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NQO1—prostate cancer	2.25e-06	7.54e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—INS—prostate cancer	2.24e-06	7.51e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.23e-06	7.46e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCG5—prostate cancer	2.23e-06	7.46e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TH—prostate cancer	2.22e-06	7.43e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CREBBP—prostate cancer	2.2e-06	7.36e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP3A4—prostate cancer	2.2e-06	7.35e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA1—prostate cancer	2.18e-06	7.29e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1B1—prostate cancer	2.16e-06	7.23e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTO1—prostate cancer	2.15e-06	7.21e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.15e-06	7.21e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NAT2—prostate cancer	2.15e-06	7.21e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GGT1—prostate cancer	2.09e-06	7e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CD—prostate cancer	2.08e-06	6.98e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLCB2—prostate cancer	2.06e-06	6.91e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LRP2—prostate cancer	2.06e-06	6.91e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.06e-06	6.91e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOA1—prostate cancer	2.06e-06	6.89e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP19A1—prostate cancer	2.03e-06	6.79e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—P4HB—prostate cancer	2.02e-06	6.78e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.97e-06	6.59e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NOS3—prostate cancer	1.97e-06	6.59e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—RXRA—prostate cancer	1.96e-06	6.56e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.92e-06	6.42e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MED12—prostate cancer	1.89e-06	6.32e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—COMT—prostate cancer	1.89e-06	6.32e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTP1—prostate cancer	1.88e-06	6.29e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GNG5—prostate cancer	1.87e-06	6.27e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ITPR1—prostate cancer	1.85e-06	6.19e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CB—prostate cancer	1.82e-06	6.08e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOA3—prostate cancer	1.8e-06	6.04e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—prostate cancer	1.8e-06	6.02e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TYMS—prostate cancer	1.75e-06	5.84e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM1—prostate cancer	1.73e-06	5.78e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HPGDS—prostate cancer	1.72e-06	5.76e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.71e-06	5.73e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LPL—prostate cancer	1.69e-06	5.67e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTT1—prostate cancer	1.67e-06	5.59e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ACHE—prostate cancer	1.67e-06	5.59e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.65e-06	5.52e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1A1—prostate cancer	1.64e-06	5.48e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ERCC2—prostate cancer	1.62e-06	5.43e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.6e-06	5.37e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PRKACB—prostate cancer	1.6e-06	5.35e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.58e-06	5.29e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—prostate cancer	1.57e-06	5.25e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—prostate cancer	1.53e-06	5.11e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOA2—prostate cancer	1.51e-06	5.04e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—EP300—prostate cancer	1.5e-06	5.01e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARA—prostate cancer	1.5e-06	5.01e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.44e-06	4.81e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAV1—prostate cancer	1.41e-06	4.71e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.4e-06	4.7e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NQO1—prostate cancer	1.39e-06	4.64e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TH—prostate cancer	1.37e-06	4.58e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.33e-06	4.45e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GGT1—prostate cancer	1.29e-06	4.31e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CG—prostate cancer	1.28e-06	4.29e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOA1—prostate cancer	1.27e-06	4.25e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.25e-06	4.19e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—INS—prostate cancer	1.21e-06	4.06e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—RXRA—prostate cancer	1.21e-06	4.04e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CREBBP—prostate cancer	1.19e-06	3.98e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—COMT—prostate cancer	1.16e-06	3.89e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTP1—prostate cancer	1.16e-06	3.87e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ITPR1—prostate cancer	1.14e-06	3.81e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CD—prostate cancer	1.13e-06	3.77e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—prostate cancer	1.11e-06	3.71e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TYMS—prostate cancer	1.08e-06	3.6e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NOS3—prostate cancer	1.06e-06	3.56e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM1—prostate cancer	1.06e-06	3.56e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LPL—prostate cancer	1.04e-06	3.49e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.01e-06	3.37e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ERCC2—prostate cancer	1e-06	3.35e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CB—prostate cancer	9.82e-07	3.29e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—prostate cancer	9.73e-07	3.26e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—prostate cancer	9.4e-07	3.15e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARA—prostate cancer	9.22e-07	3.09e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—prostate cancer	9.04e-07	3.03e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAV1—prostate cancer	8.67e-07	2.9e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—prostate cancer	8.48e-07	2.84e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—EP300—prostate cancer	8.09e-07	2.71e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.89e-07	2.64e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—INS—prostate cancer	7.47e-07	2.5e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CREBBP—prostate cancer	7.32e-07	2.45e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.94e-07	2.32e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NOS3—prostate cancer	6.55e-07	2.19e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.05e-07	2.03e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—prostate cancer	5.99e-07	2.01e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—prostate cancer	5.99e-07	2e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—prostate cancer	5.23e-07	1.75e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—EP300—prostate cancer	4.98e-07	1.67e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—prostate cancer	4.89e-07	1.64e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.69e-07	1.23e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—prostate cancer	3.01e-07	1.01e-05	CbGpPWpGaD
